Journal article
The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy
Abstract
OBJECTIVES: Among warfarin-treated patients with international normalized ratio (INR) >5, we sought to determine the risk of major bleeding within 30 days.
BACKGROUND: For warfarin-treated patients, the risk of bleeding increases as the INR rises, particularly if the INR exceeds 4. The 30-day risk of hemorrhage among outpatients with excessively prolonged INR values is unknown.
Authors
Garcia DA; Regan S; Crowther M; Hylek EM
Journal
Journal of the American College of Cardiology, Vol. 47, No. 4, pp. 804–808
Publisher
Elsevier
Publication Date
February 2006
DOI
10.1016/j.jacc.2005.09.058
ISSN
0735-1097